高级检索
当前位置: 首页 > 详情页

Left thoracotomy for middle or lower thoracic esophageal carcinoma: still Sweet enough?

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China [2]Department of Thoracic Surgery, Chongqing Cancer Institute, Chongqing 400030, China
出处:
ISSN:

关键词: Esophageal squamous cell carcinoma lymphadenectomy lymph node sweet

摘要:
Esophagectomy via left thoracotomy (the Sweet procedure) has long been the conventional route for resection of esophageal carcinoma, especially in China. However, this procedure is being increasingly critiqued, mainly regarding the lymphadenectomy. The objective of this study was to compare the Sweet procedure with the right upper mediastinal lymph node resection (MS) and Ivor-Lewis (IL) procedure in the treatment of middle or lower thoracic esophageal squamous cell carcinoma (OSCC-MLT) in terms of lymphadenectomy, postoperative complications, and long-term survival. A total of 336 OSCC-MLT patients underwent radical intent surgery (188 with MS and 148 with IL procedure) between January 2007 and September 2013 in our hospital. After propensity score matching, 129 patients from each procedure were included. The efficacy of lymph node dissection at each station was estimated by the index of estimated benefit from lymph node dissection (IEBLD). IEBLD is relatively high in stations 2L, 2R, 8, 16 and 17. The metastasis rates and ratios were similar between the MS and IL procedures at each station. The MS procedure significantly outperformed the IL procedure with a shorter operating time (212 vs. 317 min), shorter in-hospital stay (10.7 vs. 15.3 days), and fewer postoperative complications (30.2% vs. 43.4%). However, the 5-year survival rates were not significantly different between the two procedures (46.9% vs. 44.0%). The MS procedure of esophagectomy is not inferior to the IL procedure in efficiency, moreover the MS procedure is safer.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 呼吸系统
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 呼吸系统
第一作者:
第一作者机构: [1]Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China [2]Department of Thoracic Surgery, Chongqing Cancer Institute, Chongqing 400030, China
通讯作者:
通讯机构: [1]Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China [*1]Department of Thoracic Surgery, West China Hospital of Sichuan University, No.37 Guoxue Alley, Chengdu 610041, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Prognostic value of right upper mediastinal lymphadenectomy in Sweet procedure for esophageal cancer. [2]The impact of occult lymph node metastasis caused by limited lymphadenectomy on node-negative esophageal carcinoma [3]Effect of cervical paraesophageal lymph node metastasis versus supraclavicular lymph node metastasis on the overall survival of patients with thoracic esophageal squamous cell carcinoma: an observational study [4]Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients With Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study [5]The impact of limited lymphadenectomy-caused occult lymph node metastasis on patients with node-negative esophageal carcinoma [6]Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis [7]Impact of two-field or three-field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis [8]Development and validation of a predictive model for overall survival in esophageal squamous cell carcinoma post-esophagectomy: the role of lymph node metastatic Stations [9]Metastasis of recurrent laryngeal nerve lymph nodes as a predictor of cervical lymph node metastasis in esophageal squamous cell carcinoma [10]Lymph node station ratio: Revised nodal category for resected esophageal squamous cell carcinoma patients

资源点击量:52808 今日访问量:0 总访问量:4561 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号